Freedom Broker analyst Zhiger Kurmet raised the price target on Diversified Healthcare Trust (NASDAQ: DHC) to $10.10 (from $10.00) while maintaining a Buy rating.

The analyst comments "Diversified Healthcare Trust (DHC) delivered a Q2'26 NFFO/ share beat, although revenue came in modestly below consensus as SHOP occupancy growth lagged expectations. While management reaffirmed its 2026 financial guidance, lower underlying SHOP occupancy assumptions indicate a more gradual ramp-up of the new operators than previously expected. We view the lower occupancy trajectory as a function of a more gradual new-operator ramp rather than softening demand, with RevPOR up 6.2% YoY, consistent with healthy underlying pricing power. The key offset was continued SHOP margin expansion (+240 bps QoQ), suggesting that the operator transition is already generating operational efficiencies ahead of a full occupancy recovery. We raise our price target for DHC to $10.10, reflecting updated estimates and multiples, and reiterate our Buy rating."